Revolution Medicines (RVMDW) News Today $0.17 -0.02 (-11.81%) As of 08/29/2025 01:29 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrendsBuy This Stock RVMDW Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Revolution Medicines (NASDAQ:RVMDW) Shares Down 0.1% - Here's What HappenedAugust 29 at 4:05 AM | americanbankingnews.comHere’s What the Wall Street Thinks About Revolution Medicines (RVMD)August 29 at 2:01 AM | finance.yahoo.comPiper Sandler Initiates Coverage of Revolution Medicines (RVMD) with an Overweight RatingAugust 23, 2025 | msn.comPiper Sandler Initiates Coverage of Revolution Medicines (RVMD) with Overweight RecommendationAugust 19, 2025 | msn.comPiper starts Revolution Medicines at Overweight on daraxonrasib potentialAugust 19, 2025 | msn.comRevolution Medicines initiated with an Outperform at LifeSci CapitalAugust 18, 2025 | msn.comRevolution Medicines initiated with an Overweight at Wells FargoAugust 16, 2025 | msn.comWells Fargo Initiates Coverage of Revolution Medicines (RVMD) with Overweight RecommendationAugust 16, 2025 | msn.comRevolution Medicines Receives FDA Breakthrough Therapy Designation for Elironrasib for Lung CancerAugust 13, 2025 | finance.yahoo.comRevolution Medicines, Iambic Therapeutics Partner to Use AI for Novel RAS-Addicted Cancer Drug DiscoveryJuly 25, 2025 | msn.comRevolution Medicines announces FDA BTD to elironrasibJuly 23, 2025 | msn.comRevolution Medicines’ Daraxonrasib Granted FDA Breakthrough Therapy Designation for Pancreatic Cancer with KRAS G12 MutationsJuly 9, 2025 | insidermonkey.comRevolution Medicines, Inc. (RVMD) - Yahoo FinanceJuly 5, 2025 | finance.yahoo.comRevolution Medicines Secures $2 Billion Flexible Financing Deal with Royalty PharmaJune 24, 2025 | msn.comRevolution Medicines To Get Up To $2B For Development Of Cancer Drug From Royalty PharmaJune 24, 2025 | msn.comThis Revolution Medicines Insider Increased Their Holding In The Last YearJune 20, 2025 | finance.yahoo.comRevolution Medicines, Inc. (RVMDW)June 10, 2025 | finance.yahoo.comWe Think Revolution Medicines (NASDAQ:RVMD) Can Afford To Drive Business GrowthMay 10, 2025 | finance.yahoo.comEarnings call transcript: Revolution Medicines sees stock surge after Q1 2025 updateMay 9, 2025 | uk.investing.comRevolution Medicines Inc (RVMD) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ...May 8, 2025 | finance.yahoo.comRevolution Medicines: Overpriced RAS-Addicted Cancers MavenApril 8, 2025 | seekingalpha.comRevolution Medicines price target lowered to $64 from $78 at StifelApril 1, 2025 | markets.businessinsider.comIs Revolution Medicines, Inc. (RVMD) Among Stocks With At Least $20 Million In Insider Spending Recently?March 6, 2025 | msn.comRevolution Medicines price target raised to $73 from $72 at H.C. WainwrightMarch 3, 2025 | markets.businessinsider.comJ.P. Morgan Reaffirms Their Buy Rating on Revolution Medicines (RVMD)February 28, 2025 | markets.businessinsider.comPiper Sandler Sticks to Its Buy Rating for Revolution Medicines (RVMD)February 28, 2025 | markets.businessinsider.comTD Cowen Reaffirms Their Buy Rating on Revolution Medicines (RVMD)February 27, 2025 | markets.businessinsider.comRevolution Medicines Q4 2024 Earnings PreviewFebruary 26, 2025 | msn.comRevolution Medicines' SWOT analysis: stock shows promise amid cancer treatment advancesFebruary 4, 2025 | msn.comRevolution Medicines (RVMD) Receives a Buy from BarclaysJanuary 22, 2025 | markets.businessinsider.comIs Revolution Medicines, Inc. (RVMD) the Best Russell 2000 Stock to Invest in According to Analysts?January 18, 2025 | msn.comStocks Generating Improved Relative Strength: Revolution MedicinesJanuary 15, 2025 | msn.comRevolution Medicines (RVMD) Gets a Buy from Bank of America SecuritiesJanuary 14, 2025 | markets.businessinsider.com Get Revolution Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for RVMDW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RVMDW Media Mentions By Week RVMDW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RVMDW News Sentiment▼0.851.11▲Average Medical News Sentiment RVMDW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RVMDW Articles This Week▼31▲RVMDW Articles Average Week Get the Latest News and Ratings for RVMDW and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Revolution Medicines and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies 60 Degrees Pharmaceuticals News Today Alpha Tau Medical News Today BriaCell Therapeutics News Today enGene News Today Fortress Biotech News Today GeoVax Labs News Today Jasper Therapeutics News Today Lexaria Bioscience News Today NewAmsterdam Pharma News Today Nutriband News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RVMDW) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | SponsoredDid you spot this in the Oval Office last week?When Tim Cook stood in the Oval Office last week, all eyes were on the "unique 24K gold gift" he presented to ...InvestorPlace | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revolution Medicines, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revolution Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RVMDW Stock Alerts